NS 1738产品描述：NS1738 is a novel positive allosteric modulator of the α7 nAChR, with respect to positive modulation of α7 nAChR (EC₅₀=3.4 μM in oocyte experiments).IC50 & Target: EC50: 3.4 μM (α7 nAChR, in oocyte experiments)^[1]In Vitro: NS1738 acts by increasing the peak amplitude of acetylcholine (ACh)-evoked currents at all concentrations; thus, it increased the maximal efficacy of ACh. Plotting peak current amplitude against the logarithm of the NS1738 concentration used for preincubation reveals a sigmoidal concentration-response relationship that is well fit by the Hill equation (EC₅₀=3.4 μM). Under similar experimental conditions, NS1738 shows comparable efficacy and potency at the rat α7 nAChR (EC₅₀=3.9 μM)^[1].In Vivo: To estimate the ability of NS1738 to permeate the blood-brain barrier, rats are administered 10 mg/kg NS1738 intraperitoneally. Peak brain concentrations are measured approximately 30 min after injection, and they amount to ~80 ng/mL (~200 nM) at this dose. The ratio between the amount of compound entering the brain and that in plasma is AUC _brain /AUC _plasma =0.50. The half-life in plasma is estimated to 42 min. Incubation of NS1738 with isolated liver microsomes in vitro indicates that approximately 60 and 75% of NS1738 is metabolized via the cytochrome P450 system in mouse and rat, respectively, within 1 h. Adult rats administered NS1738 at 10 and 30 mg/kg i.p. immediately following the initial exposure to a juvenile rat (T1) display significant decreases in the investigative duration of a subsequent exposure to the same juvenile (T2) 2 h later (T2/T1 ratio of 0.69±0.13 and 0.61±0.07, respectively)^[1].
产品链接：www.medchemexpress.com/NS_1738.html

研究领域：Membrane Transporter/Ion Channel

靶点：nAChR

相关产品：PNU-282987  |  Carbamoylcholine chloride  |  GTS-21 dihydrochloride  |  Varenicline  |  Monepantel  |  PNU-120596  |  Catharanthine  |  Hexamethonium Bromide  |  Aniracetam  |  Tebanicline hydrochloride  |  Dinotefuran  |  EVP-6124 hydrochloride  |  ZSET1446  |  A-867744  |  Adiphenine hydrochloride  |  



公司介绍：MedChemExpress(MCE)专注于各种抑制剂、激动剂、API及化合物库，总部位于美国新泽西，分别在瑞典和上海设有欧洲区子公司和亚洲区总代理，营销网点遍及全球20多个国家地区。MCE经过多年努力已成为全球生物活性小分子领域的一流供应商， 产品涵盖癌症、神经科学、抗感染、表观遗传学等20个热门研究领域，PI3K、MAPK等近千个细分靶点，超过4000个活性小分子化合物现货，以及GPCR、API、离子通道等超过20种不同类型的化合物库，同时提供从毫克到千克的专业定制合成服务。
MCE 对每批产品都进行严格的LCMS和NMR检验，其产品已被全球近万名客户广泛使用并发表大量文章、；
MCE 定期增加各领域热门抑制剂、激动剂，不断扩增已有化合物库，以满足*新的科研需求；
数千种产品在上海有充足备货，24-48小时内送达客户；
大量产品提供免费试用装；已为全球多个知名企业、院校构建各种定制型化合物库。

更新时间：2024/1/2 10:10:55